Action Novartis - NVS

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

107,75

Prix Achat

Prix Vente

Volume échangé

1 522 443

106,43 Fourchette du Jour 107,9885

92,35 Plage de 52 semaines 120,92

Cap du marché

220,245B

Clôture Veille

106,85

Ouverture

106,61

Dernière Transaction

108

Dernière heure de transaction

Volume financier

US$ 163 443 071

VWAP

107,3558

Volume moyen (3 m)

1 473 147

Actions en circulation

2 044 033 986

Rendement du Dividende

Ratio Cours sur Bénéfices

18,23

Bénéfice par action (BPA)

5,84

Chiffre d'affairess

51,72B

Bénéfice net

11,94B

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, ca... Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.novartis.com

Siège social

Basel, Che

Fondé

Novartis AG est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker NVS. Le dernier cours de clôture d'Novartis était de US$106,85. Au cours de la dernière année, les actions de Novartis ont été négociées dans une fourchette de prix de US$ 92,35 à US$ 120,92.

Novartis compte actuellement 2 044 033 986 actions en circulation. La capitalisation boursière d'Novartis est de US$218,41 milliard. Novartis a un ratio cours/bénéfice (ratio PE) de 18.23.

Flux global

Haussier

Prime nette

2M

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

600,00%

Sweeps Ratio

28,57%

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program

PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate

Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer PR...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	2.19	2.07464948844	105.56	110.075	104.91	2144448	107.28673405	DR
4	9	9.11392405063	98.75	110.075	97.39	2190860	103.211669	DR
12	5.21	5.08094402185	102.54	110.075	96.23	1473147	101.75575294	DR
26	-3.71	-3.32854835816	111.46	120.92	96.23	1243865	107.38779313	DR
52	8.19	8.22619525914	99.56	120.92	92.35	1354907	104.45592614	DR
156	21.58	25.043518626	86.17	120.92	74.09	1784833	93.79386467	DR
260	9.93	10.151298303	97.82	120.92	69.1	1915779	90.65282353	DR

NVS - Frequently Asked Questions (FAQ)

What is the current Novartis share price?

The current share price of Novartis is US$ 107,75

How many Novartis shares are in issue?

Novartis has 2 044 033 986 shares in issue

What is the market cap of Novartis?

The market capitalisation of Novartis is USD 218,41B

What is the 1 year trading range for Novartis share price?

Novartis has traded in the range of US$ 92,35 to US$ 120,92 during the past year

What is the PE ratio of Novartis?

The price to earnings ratio of Novartis is 18,23

What is the cash to sales ratio of Novartis?

The cash to sales ratio of Novartis is 4,21

What is the reporting currency for Novartis?

Novartis reports financial results in USD

What is the latest annual turnover for Novartis?

The latest annual turnover of Novartis is USD 51,72B

What is the latest annual profit for Novartis?

The latest annual profit of Novartis is USD 11,94B

What is the registered address of Novartis?

The registered address for Novartis is PO BOX, BASEL, 4002

What is the Novartis website address?

The website address for Novartis is www.novartis.com

Which industry sector does Novartis operate in?

Novartis operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SLQTSelectQuote Inc	US$ 5,731 (30,84%)	29,71M
MYTEMYT Netherlands Parent BV	US$ 12,41 (24,10%)	437,45k
BPTBP Prudhoe Bay Royalty Trust	US$ 0,69 (16,32%)	767,54k
KUKEKuke Music Holding Limited	US$ 0,4459 (12,88%)	158,41k
NOTEFiscaNote Holdings Inc	US$ 1,87 (12,65%)	17,08M
NGLNGL Energy Partners LP	US$ 4,3698 (-20,55%)	1,13M
DAOYoudao Inc	US$ 8,94 (-19,46%)	585,79k
PSFEPaysafe Limited	US$ 18,96 (-16,81%)	1,51M
CHPTChargePoint Holdings Inc	US$ 0,683 (-13,53%)	70,28M
LMNDLemonade Inc	US$ 32,82 (-13,13%)	3,3M
BBAIBigBear ai Holdings Inc	US$ 8,00 (-8,26%)	119,1M
CHPTChargePoint Holdings Inc	US$ 0,683 (-13,53%)	70,28M
NIONIO Inc	US$ 4,045 (-6,58%)	69,23M
SCHWCharles Schwab Corporation	US$ 83,20 (2,50%)	59,34M
ACHRArcher Aviation Inc	US$ 9,285 (-8,97%)	59,14M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Novartis AG (NVS) Cours

Novartis AG (NVS)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Novartis AG

Flux d'options Novartis (NVS)

Flux global

Haussier

Prime nette

2M

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

600,00%

Sweeps Ratio

28,57%

NVS Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate

Tesla Sales Drop; Intel to Exit Dow Jones After 25 Years; VKTX and ATSG Surge Over 20% Pre-Market

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

HSBC Reports $8.5 Billion Profit; Boot Barn Announces New CEO and Projections; TMDX Drops 24%, VFC Surges 22%

NVS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités